Top Marketing News
Weekly edition | July 18, 2018
BROUGHT TO YOU BY — BioPharma Dive Brand Studio
- How molecular biomarkers are transforming cancer treatment
- AbbVie goes 3-0 in delaying Humira rivals
- Drug lobby aims to shake up how medicines are paid for
- Where does J&J’s new drug fit in the crowded HIV market?
- 5 drugs to watch as biotechs report Q2
- FDA seeks to make more drugs available over the counter
- Gilenya patent decision gives MS market a reprieve
PLUS >>> What they are reading:
- Trump Fails at Lowering Drug Prices as Costs Keep Going Up
- In prescription drug business, will Amazon partner with PBMs, or seek to conquer them?
- Vertex says it’s glad England made another offer for CF drugs, but it’ll have to do better
- Publicis Health acquires Payer Sciences
Read all the above via the following link >>>
About BioPharma Dive
Our mission is to provide busy execs like you with an overview of the BioPharma industry in 60 seconds. BioPharma Dive is a product of Industry Dive.
Please remember that we subscribe to receive this newsletter.
Please remember to check out the privacy policies and disclaimers, here, and there!
Many thanks ~ Carole